Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NUVB Nuvation Bio, Inc.

Trading 09-15 11:03:39 EDT

5.69

-0.25

-4.29%

High5.91	Low5.67	Vol1.62M
Open5.89	D1 Closing5.94	Amplitude4.04%
Mkt Cap2.00B	Tradable Cap1.50B	Total Shares351.12M
T/O9.41M	T/O Rate0.61%	Tradable Shares264.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NUVB","market":"US","secType":"STK","nameCN":"Nuvation Bio, Inc.","latestPrice":5.685,"timestamp":1789484618257,"preClose":5.94,"halted":0,"volume":1622559,"delay":0,"changeRate":-0.04292929292929306,"floatShares":264000000,"shares":351123233,"eps":-0.438679,"marketStatus":"Trading","change":-0.255,"latestTime":"09-15 11:03:39 EDT","open":5.8874,"high":5.91,"low":5.67,"amount":9406264.474293299,"amplitude":0.040404,"askPrice":5.69,"askSize":900,"bidPrice":5.68,"bidSize":337,"shortable":3,"etf":0,"ttmEps":-0.438679,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":5.94,"preHourTrading":{"tag":"盘前","latestPrice":5.8305,"preClose":5.94,"latestTime":"09:26 EDT","volume":48043,"amount":281532.8784041,"timestamp":1789478780104,"change":-0.1095,"changeRate":-0.018434,"amplitude":0.020286},"postHourTrading":{"tag":"盘后","latestPrice":5.93,"preClose":5.94,"latestTime":"19:30 EDT","volume":115904,"amount":687978.1793,"timestamp":1789428606775,"change":-0.01,"changeRate":-0.001684,"amplitude":0.010101},"volumeRatio":1.22477,"impliedVol":1.1626,"impliedVolPercentile":0.506},"requestUrl":"/m/hq/s/NUVB","defaultTab":"news","newsList":[{"id":"2664495938","title":"Nuvation Bio CEO, CFO to Present at Citi Biopharma Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664495938","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664495938?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:07","pubTimestamp":1788379646,"startTime":"0","endTime":"0","summary":"Nuvation Bio CEO, CFO to present at Citi biopharma conference fireside chatNuvation Bio executives plan investor fireside chats at Citi’s 2026 Biopharma Back to School Conference on Sept. 9, 2026.Mana","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7xm2jG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","BK4585","LU1366192091.USD","LU0130102774.USD","LU2236285917.USD","LU1074936037.SGD","LU1506573853.SGD","LU1244550577.SGD","LU2125154935.USD","LU0320765646.SGD","LU0106831901.USD","LU0170899867.USD","LU0310800965.SGD","LU0203347892.USD","LU0648001328.SGD","LU1162221912.USD","LU1791807156.HKD","LU2417539215.USD","LU1144417596.USD","LU1244550221.USD","BK4588","BK4534","LU0477156953.USD","LU0980610538.SGD","BK4207","LU0162691827.USD","LU1244550494.USD","LU0098860793.USD","IE00BSNM7G36.USD","LU0128525689.USD","LU0052756011.USD","LU0314106906.USD","BK4559","FTXO","BK4007","IYF","LU0072461881.USD","LU2125154778.USD","LU1267930227.SGD","TFNS","LU2462157665.USD","LU1201861249.SGD","LU2456880835.USD","LU0130517989.USD","LU1668664300.SGD","BK4504","LU2360032135.SGD","NUVB","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661029080","title":"Nuvation Bio CSO Gary Hattersley Disposes of Class a Common Shares Worth $709,240","url":"https://stock-news.laohu8.com/highlight/detail?id=2661029080","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661029080?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:50","pubTimestamp":1787345436,"startTime":"0","endTime":"0","summary":"Nuvation Bio CSO Gary Hattersley disposes of Class A common shares worth $709,240Nuvation Bio Chief Scientific Officer Gary Hattersley exercised stock options for 100,000 Class A common shares on Aug.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLbNXgFb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Nuvation Bio CSO Gary Hattersley Disposes of Class a Common Shares Worth $709,240","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661647812","title":"Cantor Fitzgerald Initiates Nuvation Bio at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2661647812","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661647812?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:35","pubTimestamp":1787308556,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) has an average rating of buy and mean price target of $13.10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264632","title":"Nuvation Bio Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264632","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264632?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:24","pubTimestamp":1787307840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NUVB/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264610","title":"Nuvation Bio initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264610","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264610?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:10","pubTimestamp":1787307023,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald initiated coverage of Nuvation Bio (NUVB) with an Overweight rating and no price target The firm views Nuvation as a “low-risk, h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660281979","title":"Nuvation Bio Wins FDA Fast-Track Status for Safusidenib in IDH1-Mutant Glioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2660281979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660281979?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:01","pubTimestamp":1787227300,"startTime":"0","endTime":"0","summary":"Nuvation Bio wins FDA fast-track status for safusidenib in IDH1-mutant gliomaNuvation Bio received FDA Fast Track designation for safusidenib in IDH1-mutant glioma, a step that could speed development","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL7l2yB1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660928162","title":"Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of Idh1-Mutant Glioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2660928162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660928162?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:00","pubTimestamp":1787227204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUA5PRKGS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660515854","title":"Nuvation Bio Inc. : JP Morgan Initiates Coverage with Overweight Rating; Target Price $13","url":"https://stock-news.laohu8.com/highlight/detail?id=2660515854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660515854?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:23","pubTimestamp":1787027019,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0U0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658095829","title":"Power Solutions International And 2 More Growth Stocks With Strong Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2658095829","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658095829?lang=en_us&edition=fundamental","pubTime":"2026-08-11 01:05","pubTimestamp":1786381546,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has risen by 2.7%, contributing to a 21% increase over the past year, with earnings forecasted to grow by 17% annually. In this promising environment, growth companies with high insider ownership can be particularly appealing as they often signal strong confidence from those who know the business best.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/power-solutions-international-and-2-more-growth-stocks-with","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/power-solutions-international-and-2-more-growth-stocks-with","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4182","NUVB","PSIX","HIMX","BK4526","BK4141","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657064681","title":"RBC Adjusts PT on Nuvation Bio to $20 From $19, Maintains Outperform Speculative Risk Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657064681","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657064681?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:49","pubTimestamp":1786106957,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) has an average rating of buy and mean price target of $13.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657092661","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA), Haemonetics (HAE) and Nuvation Bio (NUVB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657092661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657092661?lang=en_us&edition=fundamental","pubTime":"2026-08-07 07:00","pubTimestamp":1786057226,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Intellia Therapeutics (NTLA), Haemonetics (HAE) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-intellia-therapeutics-ntla-haemonetics-hae-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-intellia-therapeutics-ntla-haemonetics-hae-and-nuvation-bio-nuvb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","IE00B64QTZ34.USD","LU0029874061.USD","BK4556","XBI","BK4007","LU1169589451.USD","LU0012050646.USD","IE00B19Z6F94.USD","HAE","BK4137","BK4198","BK4588","HCSG","LU0205194284.USD","NTLA","LU0205193047.USD","BK4139","LU1861558580.USD","NUVB","LU1169590202.USD","LU0106261612.USD","IE00BLDYK493.USD","XLV","LU0128526141.USD","LU1861559042.SGD","BK4585","IE0034390439.USD","BK4535","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657146632","title":"Nuvation Bio Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657146632","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657146632?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:31","pubTimestamp":1786023114,"startTime":"0","endTime":"0","summary":"Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings SummaryNuvation Bio Inc.NUVB.Nreported a quarterly adjusted loss of 15 cents per share for the quarter ended June 30, higher ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4431VA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639531","title":"Nuvation Bio Posts Corporate Presentation Highlighting Ibtrozi ROS1 Lung Cancer Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639531","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639531?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:12","pubTimestamp":1786018329,"startTime":"0","endTime":"0","summary":"Nuvation Bio posts corporate presentation highlighting IBTROZI ROS1 lung cancer franchiseNuvation Bio highlighted IBTROZI (taletrectinib) as a commercial driver, cleared for advanced ROS1+ NSCLC in th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL148Pgg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657636847","title":"Earnings Flash (NUVB) Nuvation Bio Posts Q2 Net Loss of $0.18 per Share, vs. FactSet Est of $0.15 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2657636847","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657636847?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:54","pubTimestamp":1786017284,"startTime":"0","endTime":"0","summary":"Earnings Flash (NUVB) Nuvation Bio Posts Q2 Net Loss of $0.18 per Share, vs. FactSet Est of $0.15 Loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657350586","title":"Nuvation Bio Q2 Revenue Beats Estimates on Ibtrozi Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657350586","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657350586?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:53","pubTimestamp":1786017218,"startTime":"0","endTime":"0","summary":"Nuvation Bio Q2 revenue beats estimates on IBTROZI growthOverviewU.S. oncology drug developer's Q2 revenue rose and beat analyst expectationsCompany posted Q2 net loss of $62.8 mln, or $0.18 per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430LP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVB","SNDX","CHRS","BK4007","BK4535","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657635599","title":"Nuvation Bio Shares Down 2.4% Premarket After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657635599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657635599?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:37","pubTimestamp":1786016232,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL4N44315L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657963341","title":"Nuvation Bio Q2 Income from Pperations USD -51.036 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657963341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657963341?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:30","pubTimestamp":1786015804,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXD1NCBQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657633069","title":"Nuvation Bio Q2 Revenue USD 31.687 Million VS. Ibes Estimate USD 27.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657633069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657633069?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:30","pubTimestamp":1786015804,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXD1NCBQ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657334486","title":"Nuvation Bio Q2 EPS USD -0.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2657334486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657334486?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:30","pubTimestamp":1786015804,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXD1NCBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NUVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657635182","title":"Press Release: Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657635182","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657635182?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:30","pubTimestamp":1786015800,"startTime":"0","endTime":"0","summary":"Achieved $31.7 million in second quarter 2026 total revenue, including $23.2 million in net product revenue for IBTROZI(R) (taletrectinib)IBTROZI is the most prescribed ROS1 TKI in in both first-line ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","DDC","BK4588","BK4007","BK4135","SPRE","BK4585","BK4215","CNS","BK4212","MAA","NUVB","BK4022","BK4232"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1278},{"period":"1month","weight":-0.045},{"period":"3month","weight":0.1602},{"period":"6month","weight":0.3879},{"period":"1year","weight":0.8917},{"period":"ytd","weight":-0.3371}],"compareEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.0199},{"period":"3month","weight":0.0141},{"period":"6month","weight":0.1504},{"period":"1year","weight":0.1574},{"period":"ytd","weight":0.1158}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung , M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco .","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.099824},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.044723},{"month":3,"riseRate":0.5,"avgChangeRate":0.083814},{"month":4,"riseRate":0.5,"avgChangeRate":0.010626},{"month":5,"riseRate":0.666667,"avgChangeRate":0.014611},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.044383},{"month":7,"riseRate":0.666667,"avgChangeRate":0.074},{"month":8,"riseRate":0.666667,"avgChangeRate":0.020101},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.048192},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.016548},{"month":11,"riseRate":0.5,"avgChangeRate":0.163132},{"month":12,"riseRate":0.666667,"avgChangeRate":0.061496}],"exchange":"NYSE","name":"Nuvation Bio, Inc.","nameEN":"Nuvation Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Nuvation Bio, Inc.,NUVB,Nuvation Bio, Inc.股票,Nuvation Bio, Inc.股票老虎,Nuvation Bio, Inc.股票老虎国际,Nuvation Bio, Inc.行情,Nuvation Bio, Inc.股票行情,Nuvation Bio, Inc.股价,Nuvation Bio, Inc.股市,Nuvation Bio, Inc.股票价格,Nuvation Bio, Inc.股票交易,Nuvation Bio, Inc.股票购买,Nuvation Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvation Bio, Inc.(NUVB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Nuvation Bio, Inc.(NUVB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction